Zobrazit minimální záznam

An emerging Panton-Valentine leukocidin (PVL)-positive CC5-meticillin-resistant Staphylococcus aureus-IVc clone recovered from hospital and community settings over a 17-year period from 12 countries investigated by whole-genome sequencing

dc.contributor.authorAloba, Bisola K
dc.contributor.authorKinnevey, Peter M
dc.contributor.authorMonecke, Stefan
dc.contributor.authorBrennan, Gráinne I
dc.contributor.authorO'Connell, Brian
dc.contributor.authorBlomfeldt, Anita
dc.contributor.authorMcManus, Brenda A
dc.contributor.authorSchneider-Brachert, Wulf
dc.contributor.authorTkadlec, Jan
dc.contributor.authorEhricht, Ralf
dc.contributor.authorSenok, Abiola
dc.contributor.authorBartels, Mette Damkjær
dc.contributor.authorColeman, David C
dc.date.accessioned2023-07-26T10:10:25Z
dc.date.available2023-07-26T10:10:25Z
dc.date.issued2023
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1985
dc.description.abstractBACKGROUND: A novel Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) clonal complex (CC)5-MRSA-IVc ('Sri Lankan' clone) was recently described from Sri Lanka. Similar isolates caused a recent Irish hospital outbreak. AIMS: To investigate the international dissemination and diversity of PVL-positive CC5-MRSA-IVc isolates from hospital and community settings using whole-genome sequencing (WGS). METHODS: Core-genome single nucleotide polymorphic (cgSNP) analysis and multilocus sequence typing (cgMLST) and microarray-based detection of antimicrobial-resistance and virulence genes were used to investigate PVL-positive CC5-MRSA-IVc (N=214 including 46 'Sri Lankan' clone) from hospital and community settings in 12 countries over 17 years. Comparators included 29 PVL-positive and 23 PVL-negative CC5/ST5-MRSA-I/II/IVa/IVc/IVg/V. FINDINGS: Maximum-likelihood cgSNP analysis grouped 209/214 (97.7%) CC5-MRSA-IVc into Clade I; average of 110 cgSNPs between isolates. Clade III contained the five remaining CC5-MRSA-IVc; average of 92 cgSNPs between isolates. Clade II contained seven PVL-positive CC5-MRSA-IVa comparators, whereas the remaining 45 comparators formed an outlier group. Minimum-spanning cgMLST analysis revealed a comparably low average of 57 allelic differences between all CC5/ST5-MRSA-IVc. All 214 CC5/ST5-MRSA-IVc were identified as 'Sri Lankan' clone, predominantly spa type t002 (186/214) with low population diversity and harboured a similar range of virulence genes and variable antimicrobial-resistance genes. All 214 Sri Lankan clone isolates and Clade II comparators harboured a 9,616 bp chromosomal PVL-encoding phage remnant, suggesting both arose from a PVL-positive meticillin-susceptible ancestor. Over half of Sri Lankan clone isolates were from infections (142/214), and where detailed metadata were available (168/214), most were community-associated (85/168). CONCLUSIONS: Stable chromosomal retention of pvl may facilitate Sri-Lankan clone dissemination.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1016/j.jhin.2022.11.015
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleAn emerging Panton-Valentine leukocidin (PVL)-positive CC5-meticillin-resistant Staphylococcus aureus-IVc clone recovered from hospital and community settings over a 17-year period from 12 countries investigated by whole-genome sequencingen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2023-10-02T06:14:38Z
dc.subject.keywordCC5-MRSA-IVcen
dc.subject.keywordPVLen
dc.subject.keywordSri Lankan cloneen
dc.subject.keyworddisseminationen
dc.subject.keywordepidemiologyen
dc.subject.keywordphylogenomicsen
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5103
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/COOP/COOP
dc.date.embargoStartDate2023-10-02
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1016/j.jhin.2022.11.015
dc.identifier.utWos000920758900001
dc.identifier.eidScopus2-s2.0-85145710218
dc.identifier.obd619034
dc.identifier.pubmed36481685
dc.subject.rivPrimary30000::30300::30303
dcterms.isPartOf.nameJournal of Hospital Infection
dcterms.isPartOf.issn0195-6701
dcterms.isPartOf.journalYear2023
dcterms.isPartOf.journalVolume132
dcterms.isPartOf.journalIssueFebruary
uk.faculty.primaryId109
uk.faculty.primaryName2. lékařská fakultacs
uk.faculty.primaryNameSecond Faculty of Medicineen
uk.department.primaryId109
uk.department.primaryName2. lékařská fakultacs
uk.department.primaryNameSecond Faculty of Medicineen
uk.department.secondaryId1701
uk.department.secondaryNameÚstav lékařské mikrobiologiecs
uk.department.secondaryNameÚstav lékařské mikrobiologieen
dc.description.pageRange8-19
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitleAn emerging Panton-Valentine leukocidin (PVL)-positive CC5-meticillin-resistant Staphylococcus aureus-IVc clone recovered from hospital and community settings over a 17-year period from 12 countries investigated by whole-genome sequencingen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam